Persistent URL of this record https://hdl.handle.net/1887/122837
In Collections
This item can be found in the following collections:
![ILLUMINATE 301: A randomized phase III comparison of IMO-2125 with ipilimumab (ipi) versus ipi alone in subjects with anti PD 1 refractory melanoma](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
ILLUMINATE 301: A randomized phase III comparison of IMO-2125 with ipilimumab (ipi) versus ipi alone in subjects with anti PD 1 refractory melanoma
- All authors
- Ascierto, P.A.; Arenberger, P.; Atkinson, V.G.; Hansson, J.; Kapiteijn, E.; Loquai, C.; Negrier, S.; Shaw, H.M.; Tarhini, A.; Walker, J.; Geib, J.; Rahimian, S.; Swann, S.; Diab, A.
- Date
- 2018-10-01
- Title of host publication
- Annals of Oncology
- Volume
- 29